Saturday, February 13, 2021 6:18:55 AM
To quote that release partially...
Toronto, Ontario – August 19, 2020, Theralase® Technologies Inc... announced today that it has executed a Sponsored Research Agreement with the University of Manitoba Medical Microbiology department to commence development of a coronavirus vaccine and therapy utilizing Theralase’s patented and proprietary PDCs... [the approach] to be further evaluated in animal then human clinical testing in 2021.
We're still awful early in 2021, but probably (for rats) not too early to see some valid, positive initial results, given what could well be a "live or die" so-called "endpoint" evaluation.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM